| Enhancement of vaccine-mediated antitumor immunity in cancer patients after depletion of regulatory T cells J Dannull, Z Su, D Rizzieri, BK Yang, D Coleman, D Yancey, A Zhang, ... The Journal of clinical investigation 115 (12), 3623-3633, 2005 | 1244 | 2005 |
| Hedgehog signalling is essential for maintenance of cancer stem cells in myeloid leukaemia C Zhao, A Chen, CH Jamieson, M Fereshteh, A Abrahamsson, J Blum, ... Nature 458 (7239), 776-779, 2009 | 1134 | 2009 |
| Hematopoietic engraftment and survival in adult recipients of umbilical-cord blood from unrelated donors MJ Laughlin, J Barker, B Bambach, ON Koc, DA Rizzieri, JE Wagner, ... New England Journal of Medicine 344 (24), 1815-1822, 2001 | 1108 | 2001 |
| The interleukin-3 receptor alpha chain is a unique marker for human acute myelogenous leukemia stem cells CT Jordan, D Upchurch, SJ Szilvassy, ML Guzman, DS Howard, ... Leukemia 14 (10), 1777-1784, 2000 | 1026 | 2000 |
| Nuclear factor-κB is constitutively activated in primitive human acute myelogenous leukemia cells ML Guzman, SJ Neering, D Upchurch, B Grimes, DS Howard, DA Rizzieri, ... Blood, The Journal of the American Society of Hematology 98 (8), 2301-2307, 2001 | 988 | 2001 |
| The genetic landscape of mutations in Burkitt lymphoma C Love, Z Sun, D Jima, G Li, J Zhang, R Miles, KL Richards, CH Dunphy, ... Nature genetics 44 (12), 1321-1325, 2012 | 672 | 2012 |
| Genetic heterogeneity of diffuse large B-cell lymphoma J Zhang, V Grubor, CL Love, A Banerjee, KL Richards, PA Mieczkowski, ... Proceedings of the National Academy of Sciences 110 (4), 1398-1403, 2013 | 626 | 2013 |
| Disabling immune tolerance by programmed death-1 blockade with pidilizumab after autologous hematopoietic stem-cell transplantation for diffuse large B-cell lymphoma: results … P Armand, A Nagler, EA Weller, SM Devine, DE Avigan, YB Chen, ... Journal of clinical oncology 31 (33), 4199, 2013 | 553 | 2013 |
| Hematopoietic stem-cell transplantation for acute leukemia in relapse or primary induction failure M Duval, JP Klein, W He, JY Cahn, M Cairo, BM Camitta, R Kamble, ... Journal of clinical oncology 28 (23), 3730, 2010 | 510 | 2010 |
| The DOT1L inhibitor pinometostat reduces H3K79 methylation and has modest clinical activity in adult acute leukemia EM Stein, G Garcia-Manero, DA Rizzieri, R Tibes, JG Berdeja, ... Blood, The Journal of the American Society of Hematology 131 (24), 2661-2669, 2018 | 371 | 2018 |
| Tagraxofusp in blastic plasmacytoid dendritic-cell neoplasm N Pemmaraju, AA Lane, KL Sweet, AS Stein, S Vasu, W Blum, DA Rizzieri, ... New England Journal of Medicine 380 (17), 1628-1637, 2019 | 349 | 2019 |
| Safety and tolerability of guadecitabine (SGI-110) in patients with myelodysplastic syndrome and acute myeloid leukaemia: a multicentre, randomised, dose-escalation phase 1 study JPJ Issa, G Roboz, D Rizzieri, E Jabbour, W Stock, C O'Connell, K Yee, ... The lancet oncology 16 (9), 1099-1110, 2015 | 315 | 2015 |
| Umbilical cord blood expansion with nicotinamide provides long-term multilineage engraftment ME Horwitz, NJ Chao, DA Rizzieri, GD Long, KM Sullivan, C Gasparetto, ... The Journal of clinical investigation 124 (7), 3121-3128, 2014 | 298 | 2014 |
| Patterns of microRNA expression characterize stages of human B-cell differentiation J Zhang, DD Jima, C Jacobs, R Fischer, E Gottwein, G Huang, PL Lugar, ... Blood, The Journal of the American Society of Hematology 113 (19), 4586-4594, 2009 | 297 | 2009 |
| A phase 2 clinical trial of deforolimus (AP23573, MK-8669), a novel mammalian target of rapamycin inhibitor, in patients with relapsed or refractory hematologic malignancies DA Rizzieri, E Feldman, JF Dipersio, N Gabrail, W Stock, R Strair, ... Clinical Cancer Research 14 (9), 2756-2762, 2008 | 279 | 2008 |
| Deep sequencing of the small RNA transcriptome of normal and malignant human B cells identifies hundreds of novel microRNAs DD Jima, J Zhang, C Jacobs, KL Richards, CH Dunphy, WWL Choi, ... Blood, The Journal of the American Society of Hematology 116 (23), e118-e127, 2010 | 261 | 2010 |
| Partially matched, nonmyeloablative allogeneic transplantation: clinical outcomes and immune reconstitution DA Rizzieri, LP Koh, GD Long, C Gasparetto, KM Sullivan, M Horwitz, ... Journal of clinical oncology 25 (6), 690-697, 2007 | 250 | 2007 |
| Increasing use of allogeneic hematopoietic cell transplantation in patients aged 70 years and older in the United States L Muffly, MC Pasquini, M Martens, R Brazauskas, X Zhu, K Adekola, ... Blood, The Journal of the American Society of Hematology 130 (9), 1156-1164, 2017 | 241 | 2017 |
| Comparable survival after HLA-well-matched unrelated or matched sibling donor transplantation for acute myeloid leukemia in first remission with unfavorable cytogenetics at … V Gupta, MS Tallman, W He, BR Logan, E Copelan, RP Gale, HJ Khoury, ... Blood, The Journal of the American Society of Hematology 116 (11), 1839-1848, 2010 | 229 | 2010 |
| The outcome of full-intensity and reduced-intensity conditioning matched sibling or unrelated donor transplantation in adults with Philadelphia chromosome–negative acute … DI Marks, T Wang, WS Pérez, JH Antin, E Copelan, RP Gale, B George, ... Blood, The Journal of the American Society of Hematology 116 (3), 366-374, 2010 | 212 | 2010 |
